The global Psoriatic Arthritis Treatment market size is expected to be worth around US$ 18.10 billion by 2028, according to a new report by Vision Research Reports.
The global Psoriatic Arthritis Treatment market size was valued at US$ 8.10 billion in 2020 and is anticipated to grow at a CAGR of 10.9% during forecast period 2021 to 2028. Emergence of biosimilars, new product launches, and a rising consumer awareness are some of the key factors driving the growth.
Psoriatic arthritis is an inflammatory joint disease associated with psoriasis, which is categorized within the group of spondyloarthritis. It affects both the skin and musculoskeletal system. It is caused due to genetic and environmental factors. Swollen toes, fingers, and tender joints, lowered back pain, pitted nails, and stiffness are prevalent symptoms of psoriatic arthritis. Diagnosis of psoriatic arthritis is done by tests such as joint fluid test, X-ray, rheumatoid factor (RF), and magnetic resonance imaging (MRI). Psoriatic arthritis can be treated with drug class such as NSAIDs, disease-modifying antirheumatic drugs (DMARDs), biologics, and immunosuppressant drugs.
Rise in biological and biosimilar therapies, increase in prevalence of psoriatic arthritis, surge in R&D activities to develop novel drugs for the treatment of psoriatic arthritis, rise in demand for psoriatic arthritis treatment products, surge in geriatric population, strong pipeline of biosimilar & biologic products, and rise in awareness toward psoriatic arthritis treatment are the major factors that drive the growth of the global psoriatic arthritis treatment market. In addition, increase in adoption of psoriatic arthritis treatment drugs, presence of large patient pool, availability of patient assistance programs, and rise in healthcare expenditure are other factors that contribute toward the growth of the market. However, high cost of treatment and lack of standardization tools for diagnosis are expected to hinder the market growth. On the contrary, untapped potential offered by developing economies are expected to present lucrative opportunities for market expansion during the forecast period.
Biologics led the Psoriatic Arthritis (PsA) Treatment market in 2020, capturing more than half the revenue share. The drug class is not only expected to retain its dominance but is also anticipated to witness the fastest growth through the forecast period. The segment is projected to register 10.5% CAGR during the forecast period, collectively fueled by strong commercial performances of existing products and the impending launches of promising pipeline candidates.
The wave of interleukin inhibitors pose an intense competitive threat to the TNF alpha inhibitors due to their improved safety and efficacy profiles and superior results in head-to-head trials. Infliximab, guselkumab, bimekizumab, risankizumab, and tildrakizumab are some of the promising pipeline candidates, expected to propel the market growth. Furthermore, the emergence of biosimilars is a key growth rendering factor for the market.
NSAIDs are likely to lose market shares due to the availability of alternatives with improved safety and efficacy profiles and better results. DMARDs are projected to maintain their presence on account of their first-line of treatment, demand, and applicability of corticosteroids, and the forthcoming launches of key pipeline products, such as upadacitinib, filgotinib, and BMS-986165.
Prescription drugs led over Over-the-Counter (OTC) products in 2020, and are likely to maintain the lead throughout the forecast period. As most biologics and DMARDs are sold as prescriptions, the segment held the majority of revenue share in 2020.
Some NSAIDs indicated for psoriatic arthritis are available as OTC products. OTC medicines, indicated for psoriatic arthritis, are likely to lose shares over the forecast period. The declining trend is attributed to the increasing presence of biologics and biosimilars, which are sold only on prescription.
Injectables led psoriatic arthritis (PsA) treatment market, in terms of the route of administration. The segment is also likely to witness a rapid growth over the forecast period, driven by the anticipated launches of biologics and biosimilars. Most biologics are injected through the subcutaneous or intravenous routes.
North America and Europe, collectively, contributed to more than half the overall revenue in 2020. North America led the regional markets, largely driven by the commercial sales of products in the U.S. In addition, the presence of key manufacturers, proactive government initiatives, favorable reimbursement policies, and a large patient pool support the PsA treatment market growth.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period. The trend of biosimilars in emerging markets such as China, India, and South Korea, is a key propeller for growth. In addition, the overall economic development, improvement in healthcare infrastructure, increase in disposable income, and rise in consumer awareness are likely to contribute to the regional growth rate.
AbbVie Inc.; Amgen Inc.; Johnson & Johnson Services, Inc.; AstraZeneca plc; Bausch Health Companies Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Novartis International AG; Eli Lilly and Company; Pfizer, Inc.; and UCB S.A.
Drug Class Outlook
Product Type Outlook
Route of Administration Outlook
Middle East & Africa
The Psoriatic Arthritis Treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Psoriatic Arthritis Treatment market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Psoriatic Arthritis Treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriatic Arthritis Treatment market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Psoriatic Arthritis Treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Psoriatic Arthritis Treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Psoriatic Arthritis Treatment by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Psoriatic Arthritis Treatment market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Psoriatic Arthritis Treatment market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Psoriatic Arthritis Treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Psoriatic Arthritis Treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Psoriatic Arthritis Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Psoriatic Arthritis Treatment market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Psoriatic Arthritis Treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Psoriatic Arthritis Treatment market. These factors have benefited the growth of the global market for Psoriatic Arthritis Treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Psoriatic Arthritis Treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Psoriatic Arthritis Treatment are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Weight Loss Supplements Market (By Type: Liquid, Powder, Softgels, Pills; By Ingredient: Vitamins & Minerals, Amino Acids, Natural Extracts/ Botanicals; By End-user: Under 18 years, 18 to 40 years, 40 to 50 years, Above 50 years; By Distribution Channel: Offline Channel, Online Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Healthcare ERP Consulting Services Market (By Functionality: Implementation, Training & Education; By End-Use: Life Science Companies, Healthcare Providers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Articulators Market (By Product: Adjustable Articulators, Semi-adjustable Articulators, Fully Adjustable Articulators; By Material Type: Aluminum, Brass, Stainless Steel; By End-use: Hospitals, Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Veterinary Endoscopes Market (By Type: Rigid, Flexible; By Animal Type: Large Animals, Small Animals; By Application: Diagnostic, Surgical/ interventional; By Procedure: Respiratory Endoscopy, Gastrointestinal tract Endoscopy, Urinary & genital tract Endoscopy, Abdominal Endoscopy, ENT Endoscopy) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dermatology Excimer Laser Market (By Product: Table top Excimer Lasers, Hand-held Excimer Lasers, Trolley Mounted Excimer Lasers; By Application: Psoriasis, Vitiligo, Atopic Dermatitis, Allergic Rhinitis, Alopecia Areata) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...